Has FDA approved any medical products containing cannabis or cannabis-derived compounds such as CBD?.How does the 2018 Farm Bill define hemp? What does it mean for FDA-regulated products?.FDA Regulation of Dietary Supplement & Conventional Food Products Containing Cannabis and Cannabis-Derived Compoundsīelow are a number of frequently asked questions and answers on this topic.FDA and Cannabis: Research and Drug Approval Process.Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research, Draft Guidance for Industry.Warning Letters for Cannabidiol-Related Products.Scientific Conference on November 19, 2020: CBD and Other Cannabinoids: Sex and Gender Differences in Use and Responses.Information on CBD Data Collection and Submission.Reopening of the Comment Period (uncertainties and data gaps).Public Hearing, May 2019: Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds.Safety of CBD in Humans – A Literature Review.Science Board to the FDA 2022: Challenges in evaluating the safety of dietary supplement and food ingredients with predicted pharmacological activity.Remarks at the FDA Public Hearing on Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds.Congressional Testimony: Cannabis Policies for the New Decade.Congressional Testimony: Hemp Production and the 2018 Farm Bill.Remarks at the National Industrial Hemp Council 2019 Hemp Business Summit.Remarks at the Council for Responsible Nutrition Conference.Remarks at the Council for Federal Cannabis Regulation Webinar: “Understanding FDA’s Approach to Cannabis Science, Policy, and Regulation”.Stakeholder Webinar (slides): "A New Way Forward for Cannabidiol (CBD) and Other Hemp Products".What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding.What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD.5 Things to Know about Delta-8 Tetrahydrocannabinol - Delta-8 THC.FDA Warns Consumers About the Accidental Ingestion by Children of Food Products Containing THC.What the FDA is Doing to Protect Consumers from Cannabidiol (CBD) in Foods. Statement on the importance of conducting proper research to prove safe and effective medical uses for the active chemicals in marijuana and its componentsįDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsyįDA warns companies marketing unproven products, derived from marijuana, that claim to treat or cure cancer Statement on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds Statement on new steps to advance agency’s continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products FDA’s Cannabis Product Committee (CPC) develops and implements cross-Agency strategy and policy for the regulation of cannabis products.įDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way ForwardįDA Issues Response to Three Citizen Petitions related to CBD and Dietary SupplementsįDA Warns Companies for Illegally Selling Food and Beverage Products that Contain CBDįDA Warns Four Companies for Illegally Selling CBD Products Intended for Use in Food-Producing AnimalsįDA Issues Warning Letters to Companies Illegally Selling CBD and Delta-8 THC ProductsįDA Warns Companies Illegally Selling Over-the-Counter CBD Products for Pain ReliefįDA Warns Companies Illegally Selling CBD ProductsįDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic DiseaseįDA Warns Companies Illegally Selling CBD Products to Treat Medical Conditions, Opioid AddictionįDA Advances Work Related to Cannabidiol Products with Focus on Protecting Public Health, Providing Market ClarityįDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concernsįDA, FTC warn company marketing unapproved cannabidiol products with unsubstantiated claims to treat teething and ear pain in infants, autism, ADHD, Parkinson’s and Alzheimer’s diseaseįDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer's disease, opioid withdrawal, pain and pet anxietyįDA is Committed to Sound, Science-based Policy on CBD
0 Comments
Leave a Reply. |